Thermo Fisher second-quarter revenue and earnings decline over last year; shares fall in early trading
Shares in the maker of scientific and healthcare equipment fell in pre-market trading Wednesday.
Source: wfmz.com
Stay updated with breaking news from Marc Casper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares in the maker of scientific and healthcare equipment fell in pre-market trading Wednesday.
The crowning achievement of the quarter for GSK was the Food and Drug Administration’s approval of Arexvy, the first vaccine for RSV.
TMO earnings call for the period ending June 30, 2023.
The company missed Q2 Wall Street estimates on the top and bottom line and said it is implementing a $450 million cost-savings program, which will include job cuts.
Researchers expect the company to report earnings of $5.43 per share, based on the average of 11 estimates.